Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Ulcerative Colitis
NCT07349472Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of pentoxifylline in ulcerative colitis (UC) (2 arms). Primary endpoint: Change in partial Mayo score at 6 months. Started Jan 2026; status: recruiting.
02
Drugs
pentoxifylline
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07349472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07349472.